MarketInOut Stock Screener Log In | Sign Up

3SBio Inc

HKSE • Healthcare • Biotechnology • Quote as of 10/28/2026 16:08
3SBio Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeHKSE
Market Capitalization36,509 mln
Float1,931 mln
Earnings Date03/30/2027

EPS

3.70
Solid

P / E

3.70
Deeply undervalued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.33
Borderline

1-Year Forecast

31.17
Transformational upside

Relative Strength

35 / 100
Underperforming

Business Description

Founded in 1993 and headquartered in Shenyang, China, 3SBio Inc. is a biopharmaceutical company that researches, manufactures, and sells medical treatments across China and global markets. Its portfolio covers a broad range of conditions, including blood disorders, kidney disease, autoimmune conditions, cancer, and hair loss. The company also has a pipeline of new drugs in development targeting inflammation, gout, and other serious illnesses. Beyond pharmaceuticals, 3SBio provides a variety of business services spanning investment, technology, and healthcare consulting.

Key Fundamentals

EPS3.70
P/E3.70
ROE34.66
RPS8.23
ROIC55.01
ROA25.77
Interest Cover198
EBITDA, mln12,461
EV / EBITDA2.18
EV / EBIT2.30
Revenue, mln19,764
EV / Revenue1.38

Quote Details

Last 13.69
Change 0.48 (3.63%)
Open 13.39
Volume 25,489,268
Turnover 348,948,064
Average Volume 20,108,882

Financial Ratios

Pre-Tax Profit Margin60
Leverage Ratio1.29
Current Ratio6.06
Price / Book1.18
Price / Tangible Book1.46
Price / Cash Flow3.30
Price / Free Cash Flow4.01
Debt / Equity0.05
Price / Sales2.09
PEG Ratio0.12

Financial Strength

Altman Z-Score6.53
Piotroski F-Score 8 / 9
Beneish M-Score-2.33
Price to Intrinsic Value0.62
Price to Lynch Fair Value0.18
Price to Graham Number0.55
1-Year Target Price31.17
Shiller PE Ratio18.01

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.2% 31 / 100   
1 Month -14.33% 24 / 100   
2 Months -20.82% 26 / 100   
6 Months -37.32% 23 / 100   
1 Year -50.88% 19 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog